I have over 15 years of experience in Biotechnology and Synthetic Biology, with a PhD in Synthetic Biology, specialized in viral and non-viral vaccines, cell and gene therapies development, and cutting-edge nucleic acid-based technologies. As the founder and CEO of SYTE.bio, a Synthetic Biology company focused on advancing next-generation DNA and RNA-based vaccines and therapies for both human and veterinary medicine, I lead a dedicated team driving innovation in the field. My sharp focus on execution has enabled me to deliver impressive results swiftly.In addition to my role at SYTE.bio, I am the CEO and Founder of Healix Instruments, a medical device company, and previously served as Interim Chief Scientific Officer for Athergen, a Boston-based company specializing in cell reprogramming technology using miRNA. My strategic insights also extend further, as I am the founder and principal of BioConsulting Group, a global consulting firm specializing in biotechnology and synthetic biology. I also lend my expertise as a Strategic Consultant at BioStrategy Advisors LLC, a consultancy firm based in Boston. Over the years, I’ve been instrumental in assessing the scientific value of technologies, guiding research and development from discovery through pre-clinical and clinical stages, and advising start-up founders on therapies and device development, and pipeline prioritization.I also have the honor of serving as the founder and President of the Argentinean Synthetic Biology Association, the first organization of its kind in Latin America. Additionally, I am a professor of Genetic Engineering at Universidad Favaloro in Argentina. My diverse background in synthetic biology includes work on cancer treatments including melanoma and sarcoma, involving DNA, RNA, oncolytic viruses, insect and bacterial engineered viruses; as well as diseases such as Type 1 and Type 2 Diabetes, and Anemia. I’ve also contributed to the development of vaccines for rabies, dengue, and hantavirus.My expertise spans across Biotechnology, Molecular Biology, Synthetic Biology, Genetic Engineering, Bioinformatics, and the development of viral and non-viral vaccines and gene therapies. I am also skilled in patent analysis and writing, having been granted patents on groundbreaking technologies, as well as Management, Corporate Strategy, Business Development and Agreements. My mission is to drive innovation in healthcare by creating transformative medical solutions and offering strategic advice that fosters the growth of biotechnology projects.